Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4545-4551

  Zhong, Kai Ze ^a   Chen, Wei Wen ^b   Hu, Xiao Yan ^b   Jiang, An Li ^b   Zhao, Jian ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

microRNA 107; Non small cell lung cancer; Prognosis

Indexed keywords

MICRORNA; MIRN107 MICRORNA, HUMAN; TUMOR MARKER;

AGED; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84906251365     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Siegel R, Ma J, Zou Z and Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Rosell R and Karachaliou N. Lung cancer: Maintenance therapy and precision medicine in NSCLC. Nat Rev Clin Oncol 2013; 10: 549-550.
3. Miller YE. Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 2005; 33: 216-223.
4. Lin PY, Yu SL and Yang PC. MicroRNA in lung cancer. Br J Cancer 2010; 103: 1144-1148.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z and Tang KF. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012; 33: 519-528.
7. Zhang T, Liu M, Wang C, Lin C, Sun Y and Jin D. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 2011; 31: 3859-3863.
8. Guz M, Rivero-Muller A, Okon E, Stenzel-Bembenek A, Polberg K, Slomka M and Stepulak A. MicroRNAs-Role in Lung Cancer. Dis Markers 2014; 2014: 218169.
9. Daniels MG, Bowman RV, Yang IA, Govindan R and Fong KM. An emerging place for lung cancer genomics in 2013. J Thorac Dis 2013; 5: S491-S497.
10. Takahashi Y, Forrest AR, Maeno E, Hashimoto T, Daub CO and Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009; 4: e6677.
11. Kong YW, Ferland-McCollough D, Jackson TJ and Bushell M. microRNAs in cancer management. Lancet Oncol 2012; 13: e249-258.
12. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
13. Inui M, Martello G and Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-263.
14. Polster BJ, Westaway SK, Nguyen TM, Yoon MY and Hayflick SJ. Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse. Mol Genet Metab 2010; 101: 292-295.
15. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I and Nelson PT. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008; 28: 1213-1223.
16. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D and Lowenstein CJ. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A 2010; 107: 6334-6339.
17. Wang WX, Wilfred BR, Madathil SK, Tang G, Hu Y, Dimayuga J, Stromberg AJ, Huang Q, Saatman KE and Nelson PT. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 2010; 177: 334-345.
18. Feng L, Xie Y, Zhang H and Wu Y. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 2012; 29: 856-863.
19. Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT and Maitra A. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009; 9: 293-301.
20. Hennessy EJ, Sheedy FJ, Santamaria D, Barbacid M and O'Neill LA. Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6. J Biol Chem 2011; 286: 25531-25539.
21. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A and Croce CM. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24: 4677-4684.
22. Li XY, Luo QF, Wei CK, Li DF, Li J and Fang L. MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. Int J Clin Exp Med 2014; 7: 32-40.
23. Inoue T, Iinuma H, Ogawa E, Inaba T and Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012; 27: 1759-1764.